High Risk Myelodysplasia
2 clinical trials · Condition
◉ Watch High Risk Myelodysplasia
| Record | Firm | Date |
|---|---|---|
| A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS (NCT02267863) | Aptose Biosciences Inc. | 2014-10-01 |
| A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia (NCT01701375) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-09-01 |
Track High Risk Myelodysplasia automatically
Every clearance here is in the API, with alerts when new ones post.